Overview
Safety
Science
Debate
Protocol
Safety Triggers — Neuroprotection | pin.board
Safety Triggers
Neuroprotection
Known safety concerns, contraindications, and risk factors.
FDA Immunogenicity Warning
Critical
FDA Category 2 Prohibition
Critical
Oncogenic Growth Factor Stimulation
Critical
Psychiatric Contraindication
Critical
Systemic Metabolic Worsening
Severe
Receptor Desensitization from Chronic Use
Severe
Grey Market Contamination
Severe
Compounding Fraud Risk
Severe
Reproductive Safety Unknown
Severe
GI Distress from GLP-1RAs
Moderate
Injection Site Reactions
Moderate
Cardiovascular Monitoring Required
Moderate